Page last updated: 2024-11-08

aspartic acid and Brain Diseases

aspartic acid has been researched along with Brain Diseases in 134 studies

Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.

Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Research Excerpts

ExcerptRelevanceReference
"Choline is elevated in the basal ganglia and prefrontal cortical regions, suggesting regionally increased membrane turnover or glial activation in schizophrenia."9.41Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status. ( Maddock, RJ; Smucny, J; Yang, YS; Zhang, H, 2023)
" We observed mild cerebral and cerebellar atrophy and infarct at bilateral posterior putamen and insular cortex localization on conventional images and elevated choline/creatine ratios and abnormal peak at 3."7.74Neuroimaging findings in hyperargininemia. ( Akinci, A; Alkan, A; Firat, AK; Güngör, S; Tabel, Y, 2008)
"Cerebral cortex tissue was obtained at autopsy from neonatal Poll Hereford calves with clinically confirmed maple syrup urine disease (MSUD), neonatal Holstein-Friesian calves with clinically confirmed citrullinemia, and matched controls."7.68Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. ( Dennis, JA; Dodd, PR; Gundlach, AL; Harper, PA; Healy, PJ; Johnston, GA; Williams, SH, 1992)
"Choline is elevated in the basal ganglia and prefrontal cortical regions, suggesting regionally increased membrane turnover or glial activation in schizophrenia."5.41Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status. ( Maddock, RJ; Smucny, J; Yang, YS; Zhang, H, 2023)
" This biochemical information can be processed and presented as density maps of several metabolites, among them N-acetylaspartate (marker of neuronal viability), choline (marker of membrane turnover), creatine (related to the energy state of the cells), myo-Inositol (exclusively found in astrocytes), lipids and lactate (observed in necrosis and other pathological processes) which mean relevant information in the context of brain tumors."4.85Proton magnetic resonance spectroscopy imaging in the study of human brain cancer. ( Celda, B; Martínez-Bisbal, MC, 2009)
" Urine excretion of N-acetylaspartic acid was grossly increased, suggesting Canavan disease."3.81Leukodystrophy with multiple beaded periventricular cysts: unusual cranial MRI results in Canavan disease. ( Drenckhahn, A; Knierim, E; Schuelke, M, 2015)
"Higher triglyceride and lower HDL levels statistically account for the association between BMI and myo-inositol, pointing toward a potentially critical role for dyslipidemia in the development of cerebral neurochemical alterations in obesity."3.79Dyslipidemia links obesity to early cerebral neurochemical alterations. ( Gonzales, MM; Haley, AP; Tanaka, H; Tarumi, T, 2013)
" We observed mild cerebral and cerebellar atrophy and infarct at bilateral posterior putamen and insular cortex localization on conventional images and elevated choline/creatine ratios and abnormal peak at 3."3.74Neuroimaging findings in hyperargininemia. ( Akinci, A; Alkan, A; Firat, AK; Güngör, S; Tabel, Y, 2008)
"Eight patients with advanced breast cancer were entered into a prospective, longitudinal trial that included examination by MR imaging and proton MR spectroscopy before chemotherapy and through 12 months after treatment with carmustine, cyclophosphamide, and cisplatin, combined with autologous hematopoietic progenitor cell support (AHPCS)."3.70White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. ( Brown, MS; Cagnoni, PJ; Jones, RB; Sheeder, JL; Simon, JH; Stears, JC; Stemmer, SM, 1998)
"(a) Hamartomas showed higher N-acetyl aspartate/creatine, creatine/choline, and N-acetyl aspartate/choline ratios than gliomas."3.69Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation. ( Castillo, M; Green, C; Greenwood, R; Kwock, L; Schiro, S; Smith, K; Wilson, D, 1995)
" All high-grade gliomas (n = 37) showed high choline and low or absent N-acetyl-L-aspartate and creatine along with lipid and/or lactate, whereas low-grade gliomas (n = 23) were characterized by low N-acetyl-aspartate and creatine and high choline and presence of only lactate."3.69Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. ( Chhabra, DK; Gupta, RK; Jain, VK; Pandey, R; Poptani, H; Roy, R, 1995)
"Cerebral cortex tissue was obtained at autopsy from neonatal Poll Hereford calves with clinically confirmed maple syrup urine disease (MSUD), neonatal Holstein-Friesian calves with clinically confirmed citrullinemia, and matched controls."3.68Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. ( Dennis, JA; Dodd, PR; Gundlach, AL; Harper, PA; Healy, PJ; Johnston, GA; Williams, SH, 1992)
"Ornithine and arginine compounds were highly effective in preventing an increase in blood ammonia and in preventing or minimizing encephalopathy after acute subcoma, coma-inducing, or lethal doses of NH4+."3.67Ammonia toxicity: comparative protective effect of various arginine and ornithine derivatives, aspartate, benzoate, and carbamyl glutamate. ( Lyftogt, C; Raphael, D; Zieve, L, 1986)
"Most cases of the narcoleptic syndrome are considered to be idiopathic because no structural lesion is detectable, although some cases of secondary narcolepsy are known to be associated with no structural brainstem lesions."2.69Proton spectroscopy in the narcoleptic syndrome. Is there evidence of a brainstem lesion? ( Ellis, CM; Lemmens, G; Parkes, JD; Simmons, A; Williams, SC, 1998)
"Lipopolysaccharide (LPS)-induced encephalopathy induces neuroinflammation."1.51Anti-inflammatory agent, OKN-007, reverses long-term neuroinflammatory responses in a rat encephalopathy model as assessed by multi-parametric MRI: implications for aging-associated neuroinflammation. ( Gulej, R; Lawrence, B; McKenzie, T; Morton, KA; Saunders, D; Smith, N; Towner, RA, 2019)
"Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is a rare neurodegenerative disorder with various clinical presentations."1.46MR Spectroscopy in Patients with Hereditary Diffuse Leukoencephalopathy with Spheroids and Asymptomatic Carriers of Colony-stimulating Factor 1 Receptor Mutation. ( Abe, T; Fujita, K; Harada, M; Izumi, Y; Kaji, R; Kawarai, T; Matsuda, T; Matsui, N; Sakai, W; Sako, W; Terasawa, Y; Tsukamoto-Miyashiro, A, 2017)
"The histological diagnosis was anaplastic oligodendroglioma (WHO grade III)."1.37[Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma]. ( Akutsu, H; Anno, I; Isobe, T; Masumoto, T; Matsumura, A; Nakai, K; Shiigai, M; Takano, S; Yamamoto, T, 2011)
"Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) is a recently described disorder with autosomal recessive mode of inheritance."1.35Leukoencephalopathy with brain stem and spinal cord involvement and high lactate: a genetically proven case with distinct MRI findings. ( Baskan, O; Gunal, DI; Isak, B; Koseoglu, M; Ozsahin, S; Scheper, GC; Uluc, K; van der Knaap, MS; Yildirim, KA, 2008)
"In contrast, postnatal infections and hypotension are associated with an increased risk of white matter injury in the premature newborn."1.35Effect of chorioamnionitis on brain development and injury in premature newborns. ( Bowen-Roberts, T; Brant, R; Chau, V; McFadden, DE; Miller, SP; Poskitt, KJ; Sargent, MA; Soulikias, W; Synnes, A, 2009)
"Diffuse leukoencephalopathy associated with ocular malformations of the Axenfeld-Rieger type was observed in five individuals."1.34COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke. ( Arveiler, B; Bouchet, JP; Burgelin, I; Calvas, P; Coupry, I; Dousset, V; Goizet, C; Gorry, P; Lacombe, D; Menegon, P; Orgogozo, JM; Orignac, I; Sibon, I, 2007)
"Active demyelination or increased myelin turnover might contribute to the hitherto unexplained WMD of this rare disorder."1.33White-matter disease in 18q deletion (18q-) syndrome: magnetic resonance spectroscopy indicates demyelination or increased myelin turnover rather than dysmyelination. ( Anhuf, D; Häusler, M; Möller-Hartmann, W; Ramaekers, VT; Schüler, H; Thron, A; Zerres, K, 2005)
"PEHO syndrome is a rare symptom complex of severe progressive encephalopathy, edema, hypsarrhythmia, and optic atrophy."1.33Serial MR imaging, diffusion tensor imaging, and MR spectroscopic findings in a child with progressive encephalopathy, edema, hypsarrhythmia, and optic atrophy (PEHO) syndrome. ( Boltshauser, E; Huisman, TA; Klein, A; Straube, T; Werner, B, 2006)
"Most of the brain tumors were characterized by strongly reduced total N-acetylaspartyl compounds and marked increases of myo-inositol and choline-containing compounds, consistent with a lack of neuroaxonal tissue and a proliferation of glial cells."1.31Quantitative proton magnetic resonance spectroscopy of focal brain lesions. ( Dechent, P; Frahm, J; Hanefeld, F; Herms, J; Markakis, E; Maxton, C; Wilken, B, 2000)
"Two cases of reversible posterior leukoencephalopathy syndrome were examined with proton MR spectroscopic imaging."1.31Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. ( Barker, PB; Beauchamp, NJ; Eichler, FS; Wang, P; Wityk, RJ, 2002)
"Also, patients with Wilson disease and portosystemic shunting had lower myo-inositol-creatine ratios than did patients with Wilson disease and no portosystemic shunting (P < ."1.30Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy. ( Hoogenraad, TU; Mali, WP; Van Den Heuvel, AG; Van der Grond, J; Van Rooij, LG; Van Wassenaer-van Hall, HN, 1997)
"The study included 12 patients with progressive supranuclear palsy, 10 with Parkinson's disease, nine with corticobasal degeneration and 11 age-matched normal control subjects."1.30Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. ( Bertolino, A; Bonavita, S; Hallett, M; Litvan, I; Lundbom, N; Patronas, NJ; Tedeschi, G, 1997)
"However, migraine in SLE was not associated with increased disease activity or severity, neuropsychiatric manifestations, or end-organ involvement compared to patients without migraine (p > 0."1.30Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus. ( Brooks, WM; Rozell, CL; Sibbitt, WL, 1998)
"Late juvenile neuronal ceroid lipofuscinosis (NCL) is a lysosomal neurodegenerative disorder caused by the accumulation of lipopigment in neurons."1.30MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis. ( Grodd, W; Klose, U; Nägele, T; Schwab, A; Seeger, U; Seitz, D, 1998)
"Choline levels were unchanged in the lesions."1.29Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions. ( Barker, PB; Bryan, RN; Conturo, TE; Oppenheimer, SM; Preziosi, TJ; Soher, BJ, 1995)
"Four grades of demyelination and three grades of cerebral atrophy were distinguished by magnetic resonance imaging criteria."1.281H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. ( den Hollander, JA; Luyten, PR; Nauta, JJ; Valk, J; van der Grond, J; van der Knaap, MS, 1992)
"This report examines the safety issues related to the nutritive sweetener aspartame, including possible toxic effects of aspartame's component amino acids, aspartic acid and phenylalanine, and its major decomposition products, methanol and diketopiperazine, and the potential synergistic effect of aspartame and dietary carbohydrate on brain neurochemicals."1.27Aspartame. Review of safety issues. Council on Scientific Affairs. ( , 1985)
"Reversible encephalopathy was observed in 6 (7."1.26Neurotoxicity of the pyrimidine synthesis inhibitor N-phosphonoacetyl-L-aspartate. ( Casper, ES; Gralla, RJ; Kemeny, N; Wiley, RG, 1982)
"Thiamine-deficient encephalopathy in the rat is characterized by ataxic gait, loss of righting reflex and curvature of the spine."1.26Amino acid changes in thiamine-deficient encephalopathy: some implications for the pathogenesis of Friedreich's ataxia. ( Barbeau, A; Butterworth, RF; Hamel, E; Landreville, F, 1979)

Research

Studies (134)

TimeframeStudies, this research(%)All Research%
pre-199023 (17.16)18.7374
1990's40 (29.85)18.2507
2000's46 (34.33)29.6817
2010's20 (14.93)24.3611
2020's5 (3.73)2.80

Authors

AuthorsStudies
Mueller, C1
Baird, JF1
Motl, RW1
Chen, H1
Dong, Y1
Wu, Y1
Yi, F1
Yang, YS1
Smucny, J1
Zhang, H1
Maddock, RJ1
van Karnebeek, CDM1
Ramos, RJ1
Wen, XY1
Tarailo-Graovac, M1
Gleeson, JG1
Skrypnyk, C1
Brand-Arzamendi, K1
Karbassi, F1
Issa, MY1
van der Lee, R1
Drögemöller, BI1
Koster, J1
Rousseau, J1
Campeau, PM1
Wang, Y2
Cao, F1
Li, M1
Ruiter, J1
Ciapaite, J1
Kluijtmans, LAJ1
Willemsen, MAAP1
Jans, JJ1
Ross, CJ1
Wintjes, LT1
Rodenburg, RJ1
Huigen, MCDG1
Jia, Z1
Waterham, HR1
Wasserman, WW1
Wanders, RJA1
Verhoeven-Duif, NM2
Zaki, MS1
Wevers, RA1
Vidya Shankar, R1
Hu, HH1
Bikkamane Jayadev, N1
Chang, JC1
Kodibagkar, VD1
Towner, RA1
Saunders, D1
Smith, N1
Gulej, R1
McKenzie, T1
Lawrence, B1
Morton, KA1
Broeks, MH1
Shamseldin, HE1
Alhashem, A1
Hashem, M1
Abdulwahab, F1
Alshedi, T1
Alobaid, I1
Zwartkruis, F1
Westland, D1
Fuchs, S1
Jans, JJM1
Alkuraya, FS1
Wang, AP1
Suryavanshi, T1
Marcucci, M1
Fong, C1
Whitton, AC1
Reddy, KKV1
Shibasaki, J1
Niwa, T1
Piedvache, A1
Tomiyasu, M1
Morisaki, N1
Fujii, Y2
Toyoshima, K1
Aida, N1
Hübel, N1
Hosseini-Zare, MS1
Žiburkus, J1
Ullah, G1
Haley, AP1
Gonzales, MM1
Tarumi, T1
Tanaka, H1
Bladowska, J1
Zimny, A1
Knysz, B1
Małyszczak, K1
Kołtowska, A1
Szewczyk, P1
Gąsiorowski, J1
Furdal, M1
Sąsiadek, MJ1
Hansen, MB1
Kondziella, D1
Danielsen, ER1
Larsen, VA1
Jansen, EC1
Hyldegaard, O1
Drenckhahn, A1
Schuelke, M1
Knierim, E1
Chen, WS1
Li, JJ1
Hong, L1
Xing, ZB1
Wang, F1
Li, CQ1
Martinez, MA1
Florenzano, NV1
Macchia, EA1
Abe, T1
Kawarai, T1
Fujita, K1
Sako, W1
Terasawa, Y1
Matsuda, T2
Sakai, W1
Tsukamoto-Miyashiro, A1
Matsui, N1
Izumi, Y1
Kaji, R1
Harada, M1
Uluc, K1
Baskan, O1
Yildirim, KA1
Ozsahin, S1
Koseoglu, M1
Isak, B1
Scheper, GC1
Gunal, DI1
van der Knaap, MS2
Wood, PB1
Ledbetter, CR1
Glabus, MF1
Broadwell, LK1
Patterson, JC1
Josey, L1
Al Sayyari, A1
Buckley, R1
Coulthard, A1
Majós, C1
Aguilera, C1
Alonso, J1
Julià-Sapé, M1
Castañer, S1
Sánchez, JJ1
Samitier, A1
León, A1
Rovira, A1
Arús, C1
de Araújo Filho, GM1
Lin, K1
Lin, J1
Peruchi, MM1
Caboclo, LO1
Guaranha, MS1
Guilhoto, LM1
Carrete, H1
Yacubian, EM1
Chau, V1
Poskitt, KJ1
McFadden, DE1
Bowen-Roberts, T1
Synnes, A1
Brant, R1
Sargent, MA1
Soulikias, W1
Miller, SP1
Lin, YW1
Yu, CY1
Martínez-Bisbal, MC1
Celda, B1
Wu, SB1
Zhou, MQ1
Zhou, YP1
Wang, KM1
Wang, YL1
Chen, YN1
Cao, J1
Sohn, SY1
Ko, YJ1
Hong, JM1
Kim, SH1
Kim, HS1
Kim, JH1
Chi, JG1
Moon, SY1
Girard, N1
Backens, M1
Haaxma, CA1
Crow, YJ1
van Steensel, MA1
Lammens, MM1
Rice, GI1
Verbeek, MM1
Willemsen, MA1
Reith, W1
Isobe, T1
Akutsu, H1
Yamamoto, T1
Shiigai, M1
Masumoto, T1
Nakai, K1
Takano, S1
Anno, I1
Matsumura, A1
Jia, Y1
Xu, G1
Ling, X1
Liu, S1
Huang, L1
Terek, D1
Koroglu, O1
Yalaz, M1
Gokben, S1
Calli, C2
Coker, M1
Kultursay, N1
Gelal, F1
Apaydín, M1
Erdem, G1
Eichler, FS2
Itoh, R1
Barker, PB5
Mori, S1
Garrett, ES1
van Zijl, PC2
Moser, HW2
Raymond, GV1
Melhem, ER1
Smith, JK1
Londono, A1
Castillo, M2
Kwock, L2
Baslow, MH1
Suckow, RF1
Gaynor, K1
Bhakoo, KK1
Marks, N1
Saito, M2
Duff, K1
Matsuoka, Y1
Berg, MJ1
Firbank, MJ1
Minett, T1
O'Brien, JT1
Tijssen, MA1
Brown, P1
MacManus, D1
McLean, MA1
Davie, C1
Bachert, P1
Schröder, L1
Nagae-Poetscher, LM1
Bibat, G1
Philippart, M1
Rosemberg, S1
Fatemi, A1
Lacerda, MT1
Costa, MO1
Kok, F1
Costa Leite, C1
Horská, A1
Naidu, S1
Castellino, G1
Govoni, M1
Padovan, M1
Colamussi, P1
Borrelli, M1
Trotta, F1
Häusler, M1
Anhuf, D1
Schüler, H1
Ramaekers, VT1
Thron, A1
Zerres, K1
Möller-Hartmann, W1
Chang, L2
Ernst, T2
Speck, O1
Grob, CS1
Briellmann, RS1
Wellard, RM1
Jackson, GD1
Hall, NJ1
Smith, VV1
Harding, B1
Pierro, A1
Eaton, S1
De Stefano, N2
Bartolozzi, ML1
Guidi, L1
Stromillo, ML1
Federico, A1
Groeschel, S1
Brockmann, K2
Dechent, P3
Wilichowski, E1
Frahm, J4
Hanefeld, F2
Koudijs, SM1
van der Grond, J3
Hoogendoorn, ML1
Hulshoff Pol, HE1
Schnack, HG1
Witkamp, TD1
Gooskens, RH1
van Nieuwenhuizen, O1
Braun, KP1
Huisman, TA1
Klein, A1
Werner, B1
Straube, T1
Boltshauser, E1
Porto, L1
Hattingen, E1
Pilatus, U1
Kieslich, M1
Yan, B1
Schwabe, D1
Zanella, FE1
Lanfermann, H1
Mason, GF1
Di Costanzo, A2
Trojsi, F1
Tosetti, M2
Schirmer, T1
Lechner, SM1
Popolizio, T2
Scarabino, T2
Giannatempo, GM1
d'Alesio, V1
Esposito, F1
Di Salle, F1
Bertolino, A2
Maggialetti, A1
Salvolini, U1
Qiu, SJ1
Zhang, XL1
Zhang, Y1
Jiang, M1
Taylor, MJ1
Schweinsburg, BC1
Alhassoon, OM1
Gongvatana, A1
Brown, GG1
Young-Casey, C1
Letendre, SL1
Grant, I1
Sibon, I1
Coupry, I1
Menegon, P1
Bouchet, JP1
Gorry, P1
Burgelin, I1
Calvas, P1
Orignac, I1
Dousset, V1
Lacombe, D1
Orgogozo, JM1
Arveiler, B1
Goizet, C1
Kayabas, U1
Alkan, A2
Firat, AK2
Karakas, HM1
Bayindir, Y1
Yetkin, F1
Nitkunan, A1
Charlton, RA1
McIntyre, DJ1
Barrick, TR1
Howe, FA2
Markus, HS1
Güngör, S1
Akinci, A1
Tabel, Y1
Dreha-Kulaczewski, SF1
Finsterbusch, J1
Gärtner, J1
Hanefeld, FA1
Dezortova, M1
Hajek, M2
Emad, Y1
Ragab, Y1
Zeinhom, F1
El-Khouly, G1
Abou-Zeid, A1
Rasker, JJ1
Wiley, RG1
Gralla, RJ2
Casper, ES2
Kemeny, N1
Natale, RB1
Yagoda, A1
Young, CW1
Constans, JM1
Meyerhoff, DJ1
Gerson, J1
MacKay, S1
Norman, D1
Fein, G1
Weiner, MW2
Miller, BL1
McBride, D1
Cornford, M1
Oropilla, G1
Buchthal, S1
Chiang, F1
Aronow, H1
Beck, CK1
Poptani, H1
Gupta, RK1
Roy, R1
Pandey, R1
Jain, VK1
Chhabra, DK1
Kimura, H2
Itoh, S1
Iwasaki, T1
Maeda, M1
Konishi, Y1
Ishii, Y1
Tedeschi, G2
Schiffmann, R1
Barton, NW1
Shih, HH1
Gospe, SM1
Brady, RO1
Alger, JR1
Di Chiro, G1
Davie, CA1
Wenning, GK1
Barker, GJ1
Tofts, PS1
Kendall, BE1
Quinn, N1
McDonald, WI1
Marsden, CD1
Miller, DH1
Oppenheimer, SM1
Bryan, RN1
Conturo, TE1
Soher, BJ1
Preziosi, TJ1
Green, C1
Smith, K1
Wilson, D1
Schiro, S1
Greenwood, R1
Blennow, M1
Hagberg, H1
Ingvar, M1
Zeman, J1
Wang, YS1
Lagercrantz, H1
Kruse, B1
Duyn, JH1
Moonen, CT2
Olney, JW2
Hejcmanová, L1
Prádný, J1
Zelnik, N1
Luder, AS1
Elpeleg, ON1
Gross-Tsur, V1
Amir, N1
Hemli, JA1
Fattal, A1
Harel, S1
Gadian, DG1
Shaw, D1
van Zijl, P1
Matthews, PM1
Pioro, E1
Narayanan, S1
Fu, L1
Francis, G1
Antel, J1
Wolfson, C1
Arnold, DL2
Grossman, RI2
Lenkinski, RE2
Gonzalez-Scarano, F1
Tourbah, A1
Stievenart, JL1
Iba-Zizen, MT1
Zannoli, G1
Lyon-Caen, O1
Cabanis, EA1
Holshouser, BA1
Ashwal, S1
Luh, GY1
Shu, S1
Kahlon, S1
Auld, KL1
Tomasi, LG1
Perkin, RM1
Hinshaw, DB1
Jackson, EF1
Meyers, CA1
Van Den Heuvel, AG1
Van Rooij, LG1
Van Wassenaer-van Hall, HN1
Hoogenraad, TU1
Mali, WP1
Engidawork, E1
Chen, Y1
Dell'Anna, E1
Goiny, M1
Lubec, G1
Ungerstedt, U1
Andersson, K1
Herrera-Marschitz, M1
Litvan, I1
Bonavita, S1
Lundbom, N1
Patronas, NJ1
Hallett, M1
Burtscher, IM2
Ståhlberg, F1
Holtås, S2
Sanni, LA1
Thomas, SR1
Tattam, BN1
Moore, DE1
Chaudhri, G1
Stocker, R1
Hunt, NH1
Ellis, CM1
Simmons, A1
Lemmens, G1
Williams, SC1
Parkes, JD1
Brown, MS1
Stemmer, SM1
Simon, JH1
Stears, JC1
Jones, RB1
Cagnoni, PJ1
Sheeder, JL1
Cecil, KM1
Hills, EC1
Sandel, ME1
Smith, DH1
McIntosh, TK1
Mannon, LJ1
Sinson, GP1
Bagley, LJ1
Rozell, CL1
Sibbitt, WL2
Brooks, WM2
Laubenberger, J1
Bayer, S1
Thiel, T1
Hennig, J1
Langer, M1
Seitz, D1
Grodd, W1
Schwab, A1
Seeger, U1
Klose, U1
Nägele, T1
Sabet, A1
Stidley, CA1
Danska, J1
Gervais, FG1
Xu, D1
Robertson, GS1
Vaillancourt, JP1
Zhu, Y1
Huang, J1
LeBlanc, A1
Smith, D1
Rigby, M1
Shearman, MS1
Clarke, EE1
Zheng, H1
Van Der Ploeg, LH1
Ruffolo, SC1
Thornberry, NA1
Xanthoudakis, S1
Zamboni, RJ1
Roy, S1
Nicholson, DW1
Rudkin, TM1
Namer, IJ1
Bolo, NR1
Sellal, F1
Nguyen, VH1
Nedelec, JF1
Hirsch, E1
Marescaux, C1
Wilken, B1
Herms, J1
Maxton, C1
Markakis, E1
Axford, JS1
Heron, C1
Griffiths, JR1
Masoero, E1
Frattini, P1
Favalli, L1
Rozza, A1
Scelsi, R1
Govoni, S1
Blüml, S1
Moreno, A1
Hwang, JH1
Ross, BD1
Schuff, N1
Ezekiel, F1
Gamst, AC1
Amend, DL1
Capizzano, AA1
Maudsley, AA1
Wang, P1
Wityk, RJ1
Beauchamp, NJ1
Butterworth, RF2
Hamel, E1
Landreville, F1
Barbeau, A1
Perry, TL1
Currier, RD1
Hansen, S1
MacLean, J1
Bigwood, EJ1
McBride, WJ1
Aprison, MH1
Kusano, K1
Dodd, PR1
Williams, SH1
Gundlach, AL1
Harper, PA1
Healy, PJ1
Dennis, JA1
Johnston, GA1
Luyten, PR1
den Hollander, JA1
Nauta, JJ1
Valk, J2
Schwarcz, R2
Du, F1
Hoffmann, GF1
Trefz, FK1
Barth, PG1
Böhles, HJ1
Lehnert, W1
Christensen, E1
Rating, D1
Bremer, HJ1
Choi, DW1
Susel, Z1
Héroux, M1
Simon, RP1
McDonald, JW2
Uckele, J1
Silverstein, FS2
Johnston, MV2
Roeser, NF1
Echenne, B1
Divry, P1
Vianey-Liaud, C1
Bruhn, H1
Gyngell, ML1
Merboldt, KD1
Hänicke, W1
Sauter, R1
Hamburger, C1
Meldrum, B1
Wieloch, T2
Zieve, L1
Lyftogt, C1
Raphael, D1
Christie, MJ1
Beart, PM1
Jarrott, B1
Maccarrone, C1
Man, EH1
Fisher, GH1
Payan, IL1
Cadilla-Perezrios, R1
Garcia, NM1
Chemburkar, R1
Arends, G1
Frey, WH1
Simler, S1
Owsianowski, N1
Randrianarisoa, H1
Ledig, M1
Mandel, P1
Schainker, B1
Jasper, HH1
Koyama, I1
Baumgartner, R1
Scheidegger, S1
Stalder, G1
Hottinger, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Combination of 11C-MET PET and MRS in the Diagnosis of Glioma.[NCT03009318]100 participants (Actual)Interventional2012-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

20 reviews available for aspartic acid and Brain Diseases

ArticleYear
Targeting NMDA receptor signaling for therapeutic intervention in brain disorders.
    Reviews in the neurosciences, 2023, 08-28, Volume: 34, Issue:6

    Topics: Aspartic Acid; Brain; Brain Diseases; Humans; Receptors, N-Methyl-D-Aspartate; Signal Transduction

2023
Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.
    NeuroImage. Clinical, 2023, Volume: 39

    Topics: Aspartic Acid; Brain Diseases; Choline; Creatine; Humans; Magnetic Resonance Spectroscopy; Schizophr

2023
Diagnostic Value of Magnetic Resonance Spectroscopy in Radiation Encephalopathy Induced by Radiotherapy for Patients with Nasopharyngeal Carcinoma: A Meta-Analysis.
    BioMed research international, 2016, Volume: 2016

    Topics: Aspartic Acid; Brain Diseases; Carcinoma; Choline; Creatine; Humans; Magnetic Resonance Spectroscopy

2016
[Metabolism of N-acetyl-L-aspartate: its diagnostic and prognostic value].
    Revista de neurologia, 2016, Apr-16, Volume: 62, Issue:8

    Topics: Animals; Aspartic Acid; Brain Diseases; Humans; Magnetic Resonance Spectroscopy; Prognosis

2016
Proton magnetic resonance spectroscopy imaging in the study of human brain cancer.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2009, Volume: 53, Issue:6

    Topics: Aspartic Acid; Brain; Brain Diseases; Brain Neoplasms; Choline; Creatinine; Glioblastoma; Humans; In

2009
[Magnetic resonance spectroscopy for cerebral imaging].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2010, Volume: 17, Issue:6

    Topics: Apoptosis; Aspartic Acid; Asphyxia Neonatorum; Biomarkers, Tumor; Brain; Brain Diseases; Brain Disea

2010
Seizure-associated abnormalities in epilepsy: evidence from MR imaging.
    Epilepsia, 2005, Volume: 46, Issue:5

    Topics: Adult; Aspartic Acid; Atrophy; Brain; Brain Diseases; Brain Edema; Choline; Creatine; Diffusion Magn

2005
Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis.
    Journal of the neurological sciences, 2005, Jun-15, Volume: 233, Issue:1-2

    Topics: Aspartic Acid; Axons; Brain Diseases; Creatine; Disability Evaluation; Humans; Magnetic Resonance Im

2005
Proton MR spectroscopy of the brain at 3 T: an update.
    European radiology, 2007, Volume: 17, Issue:7

    Topics: Artifacts; Aspartic Acid; Brain; Brain Diseases; Brain Neoplasms; Cerebral Cortex; Choline; Creatine

2007
(1)H MR spectroscopy in pediatrics.
    European journal of radiology, 2008, Volume: 67, Issue:2

    Topics: Aspartic Acid; Brain; Brain Chemistry; Brain Diseases; Child; Child, Preschool; Choline; Creatine; G

2008
Neurochemical and biophysical assessment of neonatal hypoxic-ischemic encephalopathy.
    Seminars in perinatology, 1994, Volume: 18, Issue:1

    Topics: Animals; Aspartic Acid; Asphyxia Neonatorum; Brain; Brain Diseases; Brain Ischemia; Electrophysiolog

1994
Role of excitotoxins in developmental neuropathology.
    APMIS. Supplementum, 1993, Volume: 40

    Topics: Amino Acid Metabolism, Inborn Errors; Aspartic Acid; Brain Diseases; Brain Ischemia; Cloning, Molecu

1993
Introduction to hippocampal spectroscopy.
    Neuroimaging clinics of North America, 1997, Volume: 7, Issue:1

    Topics: Aspartic Acid; Brain Diseases; Choline; Creatine; Hippocampus; Humans; Hydrogen; Image Enhancement;

1997
Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders.
    Archives of neurology, 1999, Volume: 56, Issue:8

    Topics: Aspartic Acid; Brain Diseases; Creatine; Humans; Magnetic Resonance Spectroscopy; Neurons; Protons

1999
Proton MR spectroscopy in clinical routine.
    Journal of magnetic resonance imaging : JMRI, 2001, Volume: 13, Issue:4

    Topics: Aspartic Acid; Brain Diseases; Choline; Creatine; Humans; Lactic Acid; Magnetic Resonance Spectrosco

2001
Quinolinic acid and kynurenic acid in the mammalian brain.
    Advances in experimental medicine and biology, 1991, Volume: 294

    Topics: 3-Hydroxyanthranilate 3,4-Dioxygenase; AIDS Dementia Complex; Animals; Aspartic Acid; Biological Tra

1991
Cerebral hypoxia: some new approaches and unanswered questions.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1990, Volume: 10, Issue:8

    Topics: Animals; Aspartic Acid; Brain Diseases; Cell Survival; Cerebrovascular Circulation; Excitatory Amino

1990
[Excitatory amino acid and their involvement in pathological processes in the brain].
    Harefuah, 1990, Mar-15, Volume: 118, Issue:6

    Topics: Animals; Aspartic Acid; Brain Diseases; gamma-Aminobutyric Acid; Humans; N-Methylaspartate

1990
Role of endogenous excitatory amino acid neurotransmitters in the pathogenesis and evolution of acute brain injury.
    The Pediatric infectious disease journal, 1989, Volume: 8, Issue:12

    Topics: Acute Disease; Amino Acids; Animals; Aspartic Acid; Brain Diseases; Brain Injuries; Calcium; Calcium

1989
Neurochemical correlates to selective neuronal vulnerability.
    Progress in brain research, 1985, Volume: 63

    Topics: Adenosine; Afferent Pathways; Animals; Aspartic Acid; Brain Diseases; Brain Ischemia; Calcium; Chlor

1985

Trials

2 trials available for aspartic acid and Brain Diseases

ArticleYear
Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects.
    Neurology, 2003, Oct-14, Volume: 61, Issue:7

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Diseases; Choline; Creatine; Cross-Sectional St

2003
Proton spectroscopy in the narcoleptic syndrome. Is there evidence of a brainstem lesion?
    Neurology, 1998, Volume: 50, Issue:2 Suppl 1

    Topics: Adolescent; Adult; Aspartic Acid; Brain Diseases; Creatine; Female; Humans; Magnetic Resonance Spect

1998

Other Studies

112 other studies available for aspartic acid and Brain Diseases

ArticleYear
Whole-Brain Metabolic Abnormalities Are Associated With Mobility in Older Adults With Multiple Sclerosis.
    Neurorehabilitation and neural repair, 2022, Volume: 36, Issue:4-5

    Topics: Aged; Aspartic Acid; Brain; Brain Diseases; Choline; Creatine; Humans; Inositol; Magnetic Resonance

2022
Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy.
    American journal of human genetics, 2019, 09-05, Volume: 105, Issue:3

    Topics: Alleles; Animals; Aspartic Acid; Brain Diseases; Child; Child, Preschool; Exome Sequencing; Fatty Ac

2019
2-D magnetic resonance spectroscopic imaging of the pediatric brain using compressed sensing.
    Pediatric radiology, 2019, Volume: 49, Issue:13

    Topics: Adolescent; Age Factors; Aspartic Acid; Brain Diseases; Brain Neoplasms; Child; Child, Preschool; Co

2019
Anti-inflammatory agent, OKN-007, reverses long-term neuroinflammatory responses in a rat encephalopathy model as assessed by multi-parametric MRI: implications for aging-associated neuroinflammation.
    GeroScience, 2019, Volume: 41, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Aspartic Acid; Benzenesulfonates; Brain Diseases; Cerebral Cortex

2019
MDH1 deficiency is a metabolic disorder of the malate-aspartate shuttle associated with early onset severe encephalopathy.
    Human genetics, 2019, Volume: 138, Issue:11-12

    Topics: Age of Onset; Aspartic Acid; Brain Diseases; Child, Preschool; Female; Humans; Malate Dehydrogenase;

2019
Radiation Necrosis Following Stereotactic Radiosurgery for Trigeminal Neuralgia.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2020, Volume: 47, Issue:3

    Topics: Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neoplasms; Choline; Creatine; Diagnostic Err

2020
Comparison of Predictive Values of Magnetic Resonance Biomarkers Based on Scan Timing in Neonatal Encephalopathy Following Therapeutic Hypothermia.
    The Journal of pediatrics, 2021, Volume: 239

    Topics: Aspartic Acid; Biomarkers; Brain Diseases; Dipeptides; Gray Matter; Humans; Hypothermia, Induced; In

2021
The role of glutamate in neuronal ion homeostasis: A case study of spreading depolarization.
    PLoS computational biology, 2017, Volume: 13, Issue:10

    Topics: Animals; Aspartic Acid; Astrocytes; Brain Diseases; Cell Size; Computational Biology; Electrophysiol

2017
Dyslipidemia links obesity to early cerebral neurochemical alterations.
    Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:10

    Topics: Adult; Aspartic Acid; Blood Glucose; Blood Pressure; Body Mass Index; Brain; Brain Diseases; Cholest

2013
Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Journal of hepatology, 2013, Volume: 59, Issue:4

    Topics: Adult; Aspartic Acid; Blood Volume; Brain; Brain Diseases; Case-Control Studies; Cerebrovascular Cir

2013
Cerebral proton magnetic resonance spectroscopy demonstrates reversibility of N-acetylaspartate/creatine in gray matter after delayed encephalopathy due to carbon monoxide intoxication: a case report.
    Journal of medical case reports, 2014, Jun-19, Volume: 8

    Topics: Adult; Aspartic Acid; Brain; Brain Diseases; Carbon Monoxide Poisoning; Creatine; Female; Humans; Ma

2014
Leukodystrophy with multiple beaded periventricular cysts: unusual cranial MRI results in Canavan disease.
    Journal of inherited metabolic disease, 2015, Volume: 38, Issue:5

    Topics: Amidohydrolases; Aspartic Acid; Brain; Brain Diseases; Canavan Disease; Central Nervous System Cysts

2015
MR Spectroscopy in Patients with Hereditary Diffuse Leukoencephalopathy with Spheroids and Asymptomatic Carriers of Colony-stimulating Factor 1 Receptor Mutation.
    Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 2017, Oct-10, Volume: 16, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Brain Diseases; Female; Humans; Leukoencephalopathies; Macrophage Colony

2017
Leukoencephalopathy with brain stem and spinal cord involvement and high lactate: a genetically proven case with distinct MRI findings.
    Journal of the neurological sciences, 2008, Oct-15, Volume: 273, Issue:1-2

    Topics: Adult; Aspartate-tRNA Ligase; Aspartic Acid; Brain Diseases; Brain Stem; Creatine; Humans; Lactic Ac

2008
Hippocampal metabolite abnormalities in fibromyalgia: correlation with clinical features.
    The journal of pain, 2009, Volume: 10, Issue:1

    Topics: Adult; Aspartic Acid; Brain Diseases; Creatine; Female; Fibromyalgia; Hippocampus; Humans; Magnetic

2009
Usefulness of susceptibility-weighted imaging for voxel placement in MR spectroscopy.
    AJNR. American journal of neuroradiology, 2009, Volume: 30, Issue:4

    Topics: Artifacts; Aspartic Acid; Brain Diseases; Choline; Creatine; Electromagnetic Fields; Gadolinium; Hum

2009
Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses.
    AJNR. American journal of neuroradiology, 2009, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Diseases; Brain Neoplasms; Choline; Diagnosis, Differe

2009
Are personality traits of juvenile myoclonic epilepsy related to frontal lobe dysfunctions? A proton MRS study.
    Epilepsia, 2009, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Aspartic Acid; Brain Diseases; Creatine; Female; Frontal Lobe; Glutamic Acid; Glu

2009
Effect of chorioamnionitis on brain development and injury in premature newborns.
    Annals of neurology, 2009, Volume: 66, Issue:2

    Topics: Anisotropy; Aspartic Acid; Brain; Brain Diseases; Choline; Chorioamnionitis; Diffusion Magnetic Reso

2009
Reversible focal splenium lesion--MRS study of a different etiology.
    Acta neurologica Taiwanica, 2009, Volume: 18, Issue:3

    Topics: Adult; Aspartic Acid; Brain Diseases; Brain Mapping; Corpus Callosum; Diffusion Magnetic Resonance I

2009
[Study on the mechanism of electroacupuncture of different acupoint groups in the treatment of cerebrocardiac syndrome in rats].
    Zhen ci yan jiu = Acupuncture research, 2009, Volume: 34, Issue:5

    Topics: Acupuncture Points; Animals; Aspartic Acid; Brain; Brain Diseases; Disease Models, Animal; Electroac

2009
A case of pigmentary orthochromatic leukodystrophy with findings of proton MR spectroscopy and serial brain MRIs.
    Journal of the neurological sciences, 2010, Aug-15, Volume: 295, Issue:1-2

    Topics: Adult; Antigens, CD; Aspartic Acid; Brain; Brain Diseases; Brain Mapping; Creatine; Demyelinating Di

2010
[Basic principles of MR spectroscopy].
    Der Radiologe, 2010, Volume: 50, Issue:9

    Topics: Aspartic Acid; Biomarkers; Brain; Brain Diseases; Creatinine; Humans; Magnetic Resonance Spectroscop

2010
A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi-Goutières syndrome.
    American journal of medical genetics. Part A, 2010, Volume: 152A, Issue:10

    Topics: Adolescent; Amino Acid Substitution; Asparagine; Aspartic Acid; Brain Diseases; DNA; Exodeoxyribonuc

2010
[Magnetic resonance spectroscopy in the central nervous system].
    Der Radiologe, 2010, Volume: 50, Issue:9

    Topics: Aspartic Acid; Biomarkers; Brain; Brain Diseases; Creatinine; Humans; Magnetic Resonance Spectroscop

2010
[Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma].
    No shinkei geka. Neurological surgery, 2011, Volume: 39, Issue:5

    Topics: Adult; Aspartic Acid; Brain Diseases; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; F

2011
Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study.
    Journal of affective disorders, 2012, Volume: 136, Issue:3

    Topics: Adolescent; Adult; Aspartic Acid; Brain Chemistry; Brain Diseases; Choline; Creatine; Depressive Dis

2012
Diagnostic tools of early brain disturbances in an asymptomatic neonate with maple syrup urine disease.
    Neuropediatrics, 2013, Volume: 44, Issue:4

    Topics: Aspartic Acid; Brain Diseases; Brain Waves; Consanguinity; Developmental Disabilities; Diet; Diet, C

2013
van der Knaap's leukoencephalopathy: report of five new cases with emphasis on diffusion-weighted MRI findings.
    Neuroradiology, 2002, Volume: 44, Issue:7

    Topics: Adult; Aspartic Acid; Brain; Brain Chemistry; Brain Diseases; Child, Preschool; Choline; Creatine; C

2002
Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience.
    Radiology, 2002, Volume: 225, Issue:1

    Topics: Adolescent; Adrenoleukodystrophy; Adult; Aspartic Acid; Brain; Brain Chemistry; Brain Diseases; Chil

2002
Proton magnetic resonance spectroscopy of brain-stem lesions.
    Neuroradiology, 2002, Volume: 44, Issue:10

    Topics: Aspartic Acid; Brain; Brain Chemistry; Brain Diseases; Brain Stem; Brain Stem Neoplasms; Choline; Cr

2002
Brain damage results in down-regulation of N-acetylaspartate as a neuronal osmolyte.
    Neuromolecular medicine, 2003, Volume: 3, Issue:2

    Topics: Alzheimer Disease; Animals; Aspartic Acid; Biomarkers; Brain; Brain Diseases; Cell Survival; Cells,

2003
Magnetic resonance spectroscopy of cerebral cortex is normal in hereditary hyperekplexia due to mutations in the GLRA1 gene.
    Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:12

    Topics: Adolescent; Adult; Aspartic Acid; Brain Diseases; Brain Stem; Cerebral Cortex; Female; Frontal Lobe;

2003
[Magnetic resonance imaging spectroscopy. Part 1: Basics].
    Der Radiologe, 2003, Volume: 43, Issue:12

    Topics: Aspartic Acid; Brain; Brain Diseases; Brain Neoplasms; Choline; Energy Metabolism; Humans; Image Enh

2003
Leukoencephalopathy, cerebral calcifications, and cysts: new observations.
    Neurology, 2004, Apr-13, Volume: 62, Issue:7

    Topics: Adolescent; Aspartic Acid; Brain; Brain Diseases; Calcinosis; Central Nervous System Cysts; Child; C

2004
Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up.
    Annals of the rheumatic diseases, 2005, Volume: 64, Issue:7

    Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Chemistry; Brain Diseases; Choline; Creatine; Female;

2005
White-matter disease in 18q deletion (18q-) syndrome: magnetic resonance spectroscopy indicates demyelination or increased myelin turnover rather than dysmyelination.
    Neuroradiology, 2005, Volume: 47, Issue:1

    Topics: Aspartic Acid; Brain Diseases; Choline; Chromosome Deletion; Chromosomes, Human, Pair 18; Demyelinat

2005
Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
    The American journal of psychiatry, 2005, Volume: 162, Issue:2

    Topics: Adult; Amphetamine-Related Disorders; Aspartic Acid; Basal Ganglia; Brain; Brain Diseases; Choline;

2005
Intestinal ischemia-reperfusion injury does not lead to acute central nervous system damage.
    The Journal of surgical research, 2005, Volume: 129, Issue:2

    Topics: Acute Disease; Animals; Aspartic Acid; Brain; Brain Diseases; Gangrene; Intestinal Mucosa; Intestine

2005
Magnetic resonance imaging and proton magnetic resonance spectroscopy of megalencephaly and dilated Virchow-Robin spaces.
    Pediatric neurology, 2006, Volume: 34, Issue:1

    Topics: Aspartic Acid; Brain Diseases; Child; Child, Preschool; Choline; Creatine; Dilatation, Pathologic; D

2006
MRI, volumetry, 1H spectroscopy, and cerebropetal blood flowmetry in childhood idiopathic anatomic megalencephaly.
    Journal of magnetic resonance imaging : JMRI, 2006, Volume: 24, Issue:2

    Topics: Aspartic Acid; Blood Flow Velocity; Brain; Brain Diseases; Case-Control Studies; Cerebrovascular Cir

2006
Serial MR imaging, diffusion tensor imaging, and MR spectroscopic findings in a child with progressive encephalopathy, edema, hypsarrhythmia, and optic atrophy (PEHO) syndrome.
    AJNR. American journal of neuroradiology, 2006, Volume: 27, Issue:7

    Topics: Aspartic Acid; Atrophy; Brain Diseases; Brain Edema; Cerebellum; Child; Choline; Creatine; Diffusion

2006
Proton magnetic resonance spectroscopy in childhood brainstem lesions.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2007, Volume: 23, Issue:3

    Topics: Adolescent; Amino Acids; Aspartic Acid; Brain Chemistry; Brain Diseases; Brain Stem; Brain Stem Neop

2007
Get sober; stay sober.
    Brain : a journal of neurology, 2007, Volume: 130, Issue:Pt 1

    Topics: Alcoholism; Aspartic Acid; Brain; Brain Diseases; Choline; Creatine; Humans; Magnetic Resonance Spec

2007
3.0-T functional brain imaging: a 5-year experience.
    La Radiologia medica, 2007, Volume: 112, Issue:1

    Topics: Artifacts; Aspartic Acid; Brain; Brain Diseases; Brain Neoplasms; Cerebral Arteries; Cerebral Cortex

2007
Proton magnetic resonance spectroscopy for radiation encephalopathy induced by radiotherapy for nasopharyngeal carcinoma.
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2007, Volume: 27, Issue:3

    Topics: Adult; Aged; Aspartic Acid; Brain Diseases; Choline; Creatine; Female; Humans; Magnetic Resonance Sp

2007
Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy.
    Journal of neurovirology, 2007, Volume: 13, Issue:2

    Topics: Adult; Aspartic Acid; Basal Ganglia; Brain; Brain Diseases; CD4 Lymphocyte Count; Central Nervous Sy

2007
COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke.
    Annals of neurology, 2007, Volume: 62, Issue:2

    Topics: Adult; Anterior Eye Segment; Aspartic Acid; Autoantigens; Brain Diseases; Child; Collagen Type IV; E

2007
Magnetic resonance spectroscopy features of normal-appearing white matter in patients with acute brucellosis.
    European journal of radiology, 2008, Volume: 65, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aspartic Acid; Brain Diseases; Brucellosis; Case-Control Studies;

2008
Diffusion tensor imaging and MR spectroscopy in hypertension and presumed cerebral small vessel disease.
    Magnetic resonance in medicine, 2008, Volume: 59, Issue:3

    Topics: Aged; Aspartic Acid; Brain Diseases; Brain Ischemia; Case-Control Studies; Cerebrovascular Circulati

2008
Neuroimaging findings in hyperargininemia.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2008, Volume: 18, Issue:4

    Topics: Arginine; Aspartic Acid; Atrophy; Basal Ganglia Cerebrovascular Disease; Brain Diseases; Cerebellum;

2008
Early reduction of total N-acetyl-aspartate-compounds in patients with classical vanishing white matter disease. A long-term follow-up MRS study.
    Pediatric research, 2008, Volume: 63, Issue:4

    Topics: Adolescent; Adult; Aspartic Acid; Axons; Brain Diseases; Cerebrum; Child; Child, Preschool; Creatine

2008
Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy.
    The Journal of rheumatology, 2008, Volume: 35, Issue:7

    Topics: Adult; Aspartic Acid; Brain Diseases; Case-Control Studies; Choline; Creatine; Female; Fibromyalgia;

2008
Neurotoxicity of the pyrimidine synthesis inhibitor N-phosphonoacetyl-L-aspartate.
    Annals of neurology, 1982, Volume: 12, Issue:2

    Topics: Adult; Aged; Animals; Antimetabolites, Antineoplastic; Aspartic Acid; Brain Diseases; Disease Models

1982
Phase I trial of PALA.
    Cancer treatment reports, 1980, Volume: 64, Issue:12

    Topics: Antineoplastic Agents; Aspartic Acid; Brain Diseases; Diarrhea; Dose-Response Relationship, Drug; Ga

1980
H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia.
    Radiology, 1995, Volume: 197, Issue:2

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Brain Diseases; Brain Ischemia; Case-Control Studies;

1995
Brain lesions in patients with AIDS: H-1 MR spectroscopy.
    Radiology, 1995, Volume: 197, Issue:2

    Topics: Abscess; Adult; AIDS Dementia Complex; Aspartic Acid; Brain Diseases; Brain Neoplasms; Choline; Crea

1995
Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
    AJNR. American journal of neuroradiology, 1995, Volume: 16, Issue:8

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Diseases; Brain Neoplasms; Child; Choline; Crea

1995
Metabolic alterations in the neonate and infant brain during development: evaluation with proton MR spectroscopy.
    Radiology, 1995, Volume: 194, Issue:2

    Topics: Aspartic Acid; Brain; Brain Diseases; Choline; Creatinine; Developmental Disabilities; Humans; Infan

1995
Proton magnetic resonance spectroscopic imaging in childhood ataxia with diffuse central nervous system hypomyelination.
    Neurology, 1995, Volume: 45, Issue:8

    Topics: Aspartic Acid; Ataxia; Brain; Brain Diseases; Child, Preschool; Choline; Creatine; Female; Gaucher D

1995
Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy.
    Annals of neurology, 1995, Volume: 37, Issue:2

    Topics: Adult; Aged; Aspartic Acid; Atrophy; Basal Ganglia; Brain Diseases; Choline; Creatine; Diagnosis, Di

1995
Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions.
    Magnetic resonance in medicine, 1995, Volume: 33, Issue:1

    Topics: Adult; Aged; Aspartic Acid; Brain; Brain Chemistry; Brain Diseases; Cerebrovascular Circulation; Cer

1995
Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.
    AJNR. American journal of neuroradiology, 1995, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Aspartic Acid; Astrocytoma; Brain; Brain Diseases; Brain Neoplasms; Cerebellar Di

1995
Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy.
    Annals of neurology, 1994, Volume: 36, Issue:4

    Topics: Adolescent; Adrenoleukodystrophy; Adult; Aged; Aspartic Acid; Brain Diseases; Child; Child, Preschoo

1994
Proton in vivo spectroscopy of patients with hyperphenylalaninaemia.
    Neuropediatrics, 1993, Volume: 24, Issue:2

    Topics: Adult; Aspartic Acid; Biopterins; Brain; Brain Chemistry; Brain Diseases; Child; Choline; Creatine;

1993
Protracted clinical course for patients with Canavan disease.
    Developmental medicine and child neurology, 1993, Volume: 35, Issue:4

    Topics: Adolescent; Amidohydrolases; Aspartic Acid; Brain Diseases; Child; Child, Preschool; Female; Fibrobl

1993
Advances in proton magnetic resonance spectroscopy of the brain. A report on a workshop held in Oxford, England December 16-18, 1992.
    Magnetic resonance in medicine, 1993, Volume: 30, Issue:1

    Topics: Aspartic Acid; Biomarkers; Brain; Brain Chemistry; Brain Diseases; England; Humans; Hydrogen; Magnet

1993
Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy.
    Brain : a journal of neurology, 1996, Volume: 119 ( Pt 3)

    Topics: Adult; Aspartic Acid; Brain Diseases; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance

1996
Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease.
    AJNR. American journal of neuroradiology, 1996, Volume: 17, Issue:8

    Topics: Adult; Aspartic Acid; Brain; Brain Diseases; Brain Edema; Choline; Chronic Disease; Creatine; Demyel

1996
In vivo localized NMR proton spectroscopy of normal appearing white matter in patients with multiple sclerosis.
    Journal of neuroradiology = Journal de neuroradiologie, 1996, Volume: 23, Issue:2

    Topics: Adult; Analysis of Variance; Aspartic Acid; Brain; Brain Diseases; Choline; Clinical Trials as Topic

1996
Proton MR spectroscopy after acute central nervous system injury: outcome prediction in neonates, infants, and children.
    Radiology, 1997, Volume: 202, Issue:2

    Topics: Adolescent; Aspartic Acid; Brain; Brain Diseases; Brain Injuries; Child; Choline; Discriminant Analy

1997
Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy.
    Radiology, 1997, Volume: 203, Issue:2

    Topics: Adult; Aged; Aspartic Acid; Brain; Brain Diseases; Choline; Creatinine; Diagnosis, Differential; Fem

1997
Effect of perinatal asphyxia on systemic and intracerebral pH and glycolysis metabolism in the rat.
    Experimental neurology, 1997, Volume: 145, Issue:2 Pt 1

    Topics: Animals; Aspartic Acid; Behavior, Animal; Brain Chemistry; Brain Diseases; Corpus Striatum; Female;

1997
Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.
    Brain : a journal of neurology, 1997, Volume: 120 ( Pt 9)

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Diseases; Choline; Creatine; Female; Humans; Ma

1997
Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions.
    Acta radiologica (Stockholm, Sweden : 1987), 1997, Volume: 38, Issue:6

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neo

1997
Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
    The American journal of pathology, 1998, Volume: 152, Issue:2

    Topics: Animals; Aspartic Acid; Brain; Brain Diseases; Female; Glutamic Acid; Indoleamine-Pyrrole 2,3,-Dioxy

1998
White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy.
    AJNR. American journal of neuroradiology, 1998, Volume: 19, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Brain; Brain Diseases; B

1998
Proton magnetic resonance spectroscopy for detection of axonal injury in the splenium of the corpus callosum of brain-injured patients.
    Journal of neurosurgery, 1998, Volume: 88, Issue:5

    Topics: Acceleration; Accidents, Traffic; Adult; Aged; Aspartic Acid; Axons; Brain Concussion; Brain Disease

1998
Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus.
    Cephalalgia : an international journal of headache, 1998, Volume: 18, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Diseases; Cohort Studies; Di

1998
[Clinical uses of proton magnetic resonance spectroscopy of the brain].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1998, Volume: 168, Issue:6

    Topics: AIDS Dementia Complex; Alzheimer Disease; Animals; Aspartic Acid; Brain; Brain Diseases; Brain Disea

1998
MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis.
    AJNR. American journal of neuroradiology, 1998, Volume: 19, Issue:7

    Topics: Aspartic Acid; Brain; Brain Diseases; Case-Control Studies; Cerebellum; Cerebral Ventricles; Child;

1998
Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus.
    Stroke, 1998, Volume: 29, Issue:11

    Topics: Adult; Antiphospholipid Syndrome; Aspartic Acid; Biomarkers; Brain Chemistry; Brain Diseases; Cerebr

1998
Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation.
    Cell, 1999, Apr-30, Volume: 97, Issue:3

    Topics: Acute Disease; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Pre

1999
Combined measurements of hippocampal N-acetyl-aspartate and T2 relaxation time in the evaluation of mesial temporal lobe epilepsy: correlation with clinical severity and memory performances.
    Epilepsia, 1999, Volume: 40, Issue:10

    Topics: Adult; Aspartic Acid; Brain Diseases; Electroencephalography; Epilepsy, Temporal Lobe; Female; Hippo

1999
Quantitative proton magnetic resonance spectroscopy of focal brain lesions.
    Pediatric neurology, 2000, Volume: 23, Issue:1

    Topics: Adolescent; Aspartic Acid; Biomarkers, Tumor; Brain; Brain Abscess; Brain Diseases; Brain Neoplasms;

2000
Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus.
    Annals of the rheumatic diseases, 2001, Volume: 60, Issue:2

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Diseases; Case-Control Studies; Choline; Creatine; Fem

2001
Effect of acute alcohol on ischemia-induced glutamate release and brain damage.
    Alcohol (Fayetteville, N.Y.), 2000, Volume: 22, Issue:3

    Topics: Animals; Aspartic Acid; Brain; Brain Diseases; Brain Ischemia; Ethanol; Frontal Lobe; Glutamic Acid;

2000
1-(13)C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders.
    NMR in biomedicine, 2001, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Diseases; Canavan Disease; Carbon Isotopes; Chi

2001
Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging.
    Magnetic resonance in medicine, 2001, Volume: 45, Issue:5

    Topics: Aged; Aged, 80 and over; Aging; Analysis of Variance; Aspartic Acid; Brain; Brain Diseases; Choline;

2001
Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome.
    AJNR. American journal of neuroradiology, 2002, Volume: 23, Issue:5

    Topics: Adult; Aspartic Acid; Brain Diseases; Choline; Confusion; Creatine; Female; Headache; Humans; Magnet

2002
Amino acid changes in thiamine-deficient encephalopathy: some implications for the pathogenesis of Friedreich's ataxia.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1979, Volume: 6, Issue:2

    Topics: Amino Acids; Animals; Aspartic Acid; Brain; Brain Diseases; Friedreich Ataxia; gamma-Aminobutyric Ac

1979
Aspartate-taurine imbalance in dominantly inherited olivopontocerebellar atrophy.
    Neurology, 1977, Volume: 27, Issue:3

    Topics: Adult; Aspartic Acid; Atrophy; Brain; Brain Diseases; Cerebellar Cortex; Cerebellar Diseases; Female

1977
Letter: L-glutamic and L-aspartic acids--a question of hazard?
    Food and cosmetics toxicology, 1975, Volume: 13, Issue:2

    Topics: Animals; Aspartic Acid; Brain Diseases; Diet; Glutamates; Humans; Hypothalamus; Infant; Sweetening A

1975
Contents of several amino acids in the cerebellum, brain stem and cerebrum of the 'staggerer', 'weaver' and 'nervous' neurologically mutant mice.
    Journal of neurochemistry, 1976, Volume: 26, Issue:5

    Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Brain; Brain Diseases; Brain Stem; Cerebellum; Disease

1976
Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves.
    Journal of neurochemistry, 1992, Volume: 59, Issue:2

    Topics: Acute-Phase Reaction; Animals; Animals, Newborn; Aspartic Acid; Brain Diseases; Cattle; Cattle Disea

1992
1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders.
    Annals of neurology, 1992, Volume: 31, Issue:2

    Topics: Adult; Aspartic Acid; Atrophy; Brain; Brain Diseases; Child; Creatine; Demyelinating Diseases; Human

1992
Macrocephaly: an important indication for organic acid analysis.
    Journal of inherited metabolic disease, 1991, Volume: 14, Issue:3

    Topics: Amino Acid Metabolism, Inborn Errors; Amino Acids; Aspartic Acid; Brain Diseases; Child; Child, Pres

1991
Effect of pyrithiamine treatment and subsequent thiamine rehabilitation on regional cerebral amino acids and thiamine-dependent enzymes.
    Journal of neurochemistry, 1989, Volume: 52, Issue:4

    Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Brain; Brain Diseases; Glutamates; Glutamic Acid; Keto

1989
HA-966 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces N-methyl-D-aspartate (NMDA)-mediated brain damage.
    Neuroscience letters, 1989, Sep-25, Volume: 104, Issue:1-2

    Topics: Animals; Animals, Newborn; Aspartic Acid; Brain Diseases; Corpus Striatum; N-Methylaspartate; Oxadia

1989
Quantitative assessment of neuroprotection against NMDA-induced brain injury.
    Experimental neurology, 1989, Volume: 106, Issue:3

    Topics: Animals; Aspartic Acid; Brain; Brain Diseases; Choline O-Acetyltransferase; Corpus Striatum; Dibenzo

1989
Spongy degeneration of the neuraxis (Canavan-van Bogaert disease) and N-acetylaspartic aciduria.
    Neuropediatrics, 1989, Volume: 20, Issue:2

    Topics: Aspartic Acid; Biopsy; Brain Diseases; Diagnosis, Differential; Humans; Infant

1989
Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.
    Radiology, 1989, Volume: 172, Issue:2

    Topics: Adult; Aspartic Acid; Brain Chemistry; Brain Diseases; Brain Neoplasms; Choline; Creatinine; Cysts;

1989
Aspartame. Review of safety issues. Council on Scientific Affairs.
    JAMA, 1985, Jul-19, Volume: 254, Issue:3

    Topics: Adolescent; Adult; Animals; Aspartame; Aspartic Acid; Brain Chemistry; Brain Diseases; Brain Neoplas

1985
Excitatory aminoacid antagonists provide a therapeutic approach to neurological disorders.
    Lancet (London, England), 1985, Jul-20, Volume: 2, Issue:8447

    Topics: Adult; Amino Acids; Animals; Aspartic Acid; Brain Diseases; Brain Ischemia; Glutamates; Humans; Hypo

1985
Endogenous excitotoxins as possible mediators of ischemic and hypoglycemic brain damage.
    Advances in experimental medicine and biology, 1986, Volume: 203

    Topics: Amino Acids; Animals; Aspartic Acid; Brain Diseases; Brain Ischemia; Calcium; Corpus Striatum; Gluta

1986
Ammonia toxicity: comparative protective effect of various arginine and ornithine derivatives, aspartate, benzoate, and carbamyl glutamate.
    Metabolic brain disease, 1986, Volume: 1, Issue:1

    Topics: Ammonia; Ammonium Chloride; Animals; Arginine; Aspartic Acid; Benzoates; Brain Diseases; Coma; Dose-

1986
Distribution of neuropeptide Y immunoreactivity in the rat basal ganglia: effects of excitotoxin lesions to caudate-putamen.
    Neuroscience letters, 1986, Jan-30, Volume: 63, Issue:3

    Topics: Animals; Aspartic Acid; Basal Ganglia; Brain Diseases; Caudate Nucleus; Male; N-Methylaspartate; Ner

1986
D-aspartate in human brain.
    Journal of neurochemistry, 1987, Volume: 48, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Aspartic Acid; Brain; Brain Di

1987
Biosynthesis of free amino acids in the brain of Jimpy mice.
    Journal of neurochemistry, 1974, Volume: 23, Issue:2

    Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Autoanalysis; Brain; Brain Diseases; Carbon Radioisoto

1974
Glutamate-type hypothalamic-pituitary syndrome in mice treated with aspartate or cysteate in infancy.
    Journal of neural transmission, 1974, Volume: 35, Issue:3

    Topics: Adipates; Alanine; Amino Acids, Dicarboxylic; Amino Acids, Sulfur; Animals; Animals, Newborn; Aspart

1974
Rate of release of amino acids from the cerebral cortex in the cat as affected by brainstem and thalamic stimulation.
    Canadian journal of physiology and pharmacology, 1969, Volume: 47, Issue:10

    Topics: Acetylcholine; Amino Acids; Aminobutyrates; Animals; Aspartic Acid; Brain Diseases; Brain Stem; Cats

1969
[Argininosuccinic aciduria disease of the newborn with lethal course].
    Helvetica paediatrica acta, 1968, Volume: 23, Issue:1

    Topics: Adult; Alanine; Amino Acids; Aminobutyrates; Anticonvulsants; Aspartic Acid; Brain Diseases; Chromat

1968